X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (84643) 84643
Newspaper Article (28133) 28133
Newsletter (24380) 24380
Book Review (19926) 19926
Publication (6378) 6378
Magazine Article (1911) 1911
Trade Publication Article (1323) 1323
Web Resource (851) 851
Book Chapter (841) 841
Book / eBook (650) 650
Conference Proceeding (494) 494
Government Document (467) 467
Transcript (351) 351
Dissertation (180) 180
Report (165) 165
Streaming Video (41) 41
Reference (38) 38
Data Set (19) 19
Journal / eJournal (5) 5
Paper (5) 5
Video Recording (5) 5
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
alzheimer's disease (68565) 68565
index medicus (57353) 57353
humans (48489) 48489
alzheimers disease (39489) 39489
alzheimers-disease (30237) 30237
neurosciences (23317) 23317
animals (23227) 23227
dementia (22852) 22852
male (21847) 21847
drug therapy (21423) 21423
medical research (21203) 21203
research (20193) 20193
female (19082) 19082
aged (18846) 18846
medicine, experimental (17487) 17487
brain (13256) 13256
alzheimer disease - drug therapy (13249) 13249
clinical neurology (10537) 10537
middle aged (9597) 9597
analysis (9439) 9439
mice (9339) 9339
neurology (8939) 8939
aged, 80 and over (8874) 8874
clinical trials (8862) 8862
reports (8695) 8695
care and treatment (8389) 8389
psychiatry (8271) 8271
pharmaceutical industry (8196) 8196
proteins (7872) 7872
pharmacology & pharmacy (7612) 7612
geriatrics & gerontology (7384) 7384
memory (7276) 7276
studies (7161) 7161
oxidative stress (6962) 6962
alzheimer’s disease (6894) 6894
alzheimer disease - metabolism (6886) 6886
risk factors (6673) 6673
neurodegenerative diseases (6652) 6652
biochemistry & molecular biology (6272) 6272
health aspects (6242) 6242
rats (6235) 6235
amyloid beta-protein (5964) 5964
drugs (5881) 5881
disease models, animal (5781) 5781
aging (5590) 5590
neurodegeneration (5585) 5585
alzheimer disease - pathology (5395) 5395
cognitive ability (5238) 5238
mild cognitive impairment (5131) 5131
neurons (5023) 5023
alzheimer disease - therapy (4910) 4910
diagnosis (4852) 4852
amyloid beta-peptides - metabolism (4759) 4759
universities and colleges (4650) 4650
medicine (4642) 4642
brain research (4596) 4596
article (4586) 4586
brain - metabolism (4580) 4580
cell biology (4580) 4580
nervous system (4539) 4539
physiological aspects (4450) 4450
nervous system diseases (4434) 4434
development and progression (4365) 4365
pathology (4316) 4316
inflammation (4290) 4290
adult (4246) 4246
cognition (4245) 4245
alzheimer disease - psychology (4210) 4210
alzheimer disease - physiopathology (4190) 4190
cancer (4172) 4172
rodents (4159) 4159
neuropsychological tests (4046) 4046
alzheimer disease - diagnosis (4009) 4009
patients (3951) 3951
alzheimer disease (3931) 3931
older people (3912) 3912
parkinsons-disease (3853) 3853
brain - pathology (3831) 3831
gerontology (3776) 3776
parkinson's disease (3716) 3716
apoptosis (3691) 3691
amyloid precursor protein (3669) 3669
alzheimer disease - genetics (3640) 3640
treatment outcome (3573) 3573
research article (3529) 3529
diabetes (3465) 3465
mice, transgenic (3442) 3442
biomarkers (3424) 3424
research & development--r&d (3391) 3391
mouse model (3346) 3346
abridged index medicus (3304) 3304
peptides (3253) 3253
multidisciplinary sciences (3233) 3233
caregivers (3221) 3221
cognitive impairment (3085) 3085
disease (3082) 3082
enzymes (3025) 3025
cholinesterase inhibitors - therapeutic use (3009) 3009
genetic aspects (2975) 2975
gene expression (2973) 2973
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (343) 343
Baycrest Hospital - Stacks (128) 128
Online Resources - Online (98) 98
Providence Healthcare - Stacks (88) 88
Collection Dvlpm't (Acquisitions) - Vendor file (62) 62
Collection Dvlpm't (Acquisitions) - Closed Orders (26) 26
Baycrest Hospital - Wellness Library (24) 24
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (21) 21
Stacks (19) 19
UofT at Mississauga - Stacks (19) 19
West Park Healthcare Centre - Stacks (17) 17
UofT at Scarborough - Stacks (16) 16
Robarts - Stacks (11) 11
Providence Healthcare - Reference (7) 7
Knox College (Caven) - Stacks (6) 6
UTL at Downsview - May be requested (5) 5
Music - Stacks (4) 4
Patient Education (4) 4
Scarborough Hospital - Online (4) 4
St. Michael's Hospital - Stacks (4) 4
Victoria University Emmanuel College - Stacks (4) 4
Architecture Landscape (Shore + Moffat) - Stacks (3) 3
Baycrest Hospital - Missing (3) 3
Bridgepoint Health - Stacks (3) 3
Holland Bloorview Kids Rehabilitation - Stacks (3) 3
Humber River Regional Hospital - Church Stacks (3) 3
Lakeridge Health Sciences - Oshawa (3) 3
Trinity College (John W Graham) - Stacks (3) 3
Victoria University E.J. Pratt - Stacks (3) 3
West Park Healthcare Centre - Hospital Department (3) 3
Baycrest Hospital - Resident/Client Library (2) 2
Credit Valley Hospital - Stacks (2) 2
Gerstein Science - Missing (2) 2
Gerstein Science - Reference (2) 2
Media Commons - Audio Visual (2) 2
New College (Ivey) - Stacks (2) 2
Scarborough Hospital - General (2) 2
St. Michael's College (John M. Kelly) - 2nd Floor (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Patient Education (2) 2
University College (Laidlaw) - Stacks (2) 2
UofT Schools - Stacks (2) 2
Baycrest Hospital - Online (1) 1
Earth Sciences (Noranda) - Stacks (1) 1
Gerstein Science - Cancelled Order (1) 1
Gerstein Science - Circulation Desk (1) 1
Gerstein Science - Not Returned (1) 1
Gerstein Science - Searching (1) 1
Humber River Regional Hospital - Keele Stacks (1) 1
Knox College (Caven) - McKay Resource Centre (1) 1
Lakeridge Health Sciences - Online (1) 1
Law (Bora Laskin) - Stacks (1) 1
Providence Healthcare - Lost (1) 1
Regis College - Stacks (1) 1
Royal Ontario Museum - Periodical Stacks (1) 1
Scarborough Hospital - Birchmount (1) 1
St. Michael's Hospital - Online (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
Trillium Health Centre - Stacks (1) 1
University College (Laidlaw) - May be requested in 6-10 wks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (140524) 140524
German (786) 786
French (595) 595
Japanese (460) 460
Spanish (376) 376
Chinese (223) 223
Russian (175) 175
Polish (104) 104
Dutch (61) 61
Italian (58) 58
Portuguese (57) 57
Swedish (46) 46
Hungarian (35) 35
Czech (31) 31
Korean (29) 29
Danish (26) 26
Finnish (18) 18
Turkish (18) 18
Norwegian (15) 15
Hebrew (9) 9
Croatian (7) 7
Persian (6) 6
Catalan (4) 4
Serbian (4) 4
Slovenian (3) 3
Hindi (2) 2
Romanian (2) 2
Slovak (2) 2
Ukrainian (2) 2
Bosnian (1) 1
Corsican (1) 1
Greek (1) 1
Lithuanian (1) 1
Urdu (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Controlled Release, ISSN 0168-3659, 06/2015, Volume 207, pp. 18 - 30
Exosomes are naturally occurring nanosized vesicles that have attracted considerable attention as drug delivery vehicles in the past few years. Exosomes are... 
Oxidative stress | Neuroinflammation | Parkinson's disease | Catalase | Exosomes | Blood–brain barrier | Blood-brain barrier | ALZHEIMERS-DISEASE | REPEATED INJECTIONS | MACROPHAGE DELIVERY | MEDIATED TRANSFER | BLOOD-BRAIN-BARRIER | BIOLOGICAL BARRIERS | CHEMISTRY, MULTIDISCIPLINARY | IN-VITRO | PEGYLATED LIPOSOMES | PHARMACOLOGY & PHARMACY | SUPEROXIDE-DISMUTASE | Antioxidants - chemistry | Antioxidants - metabolism | Oxidopamine | Anti-Inflammatory Agents - metabolism | PC12 Cells | Neuroprotective Agents - metabolism | Drug Carriers | Brain - metabolism | Nanoparticles | Parkinsonian Disorders - metabolism | Parkinsonian Disorders - drug therapy | Antiparkinson Agents - chemistry | Anti-Inflammatory Agents - administration & dosage | Female | Neurons - metabolism | Neuroprotective Agents - administration & dosage | Nanomedicine | Disease Models, Animal | Neuroprotective Agents - chemistry | Mice, Inbred C57BL | Solubility | Rats | Technology, Pharmaceutical - methods | Parkinsonian Disorders - chemically induced | Administration, Intranasal | Chemistry, Pharmaceutical | Brain - drug effects | Catalase - metabolism | Catalase - administration & dosage | Animals | Anti-Inflammatory Agents - chemistry | Antioxidants - administration & dosage | RAW 264.7 Cells | Antiparkinson Agents - administration & dosage | Mice | Kinetics | Oxidative Stress - drug effects | Antiparkinson Agents - metabolism | Catalase - chemistry | Drugs | Drug delivery systems | Proteases | Analysis | Antiparkinsonian agents | Vehicles | Index Medicus
Journal Article
Nature Medicine, ISSN 1078-8956, 07/2018, Volume 24, Issue 7, pp. 894 - 897
The pathological hallmarks of Alzheimer’s disease (AD) include extracellular beta-amyloid plaques, neurofibrillary tangles, neuronal loss and tau deposits in... 
Brain | Medical research | Neurofibrillary tangles | Tau protein | Clinical trials | β-Amyloid | Alzheimer's disease | Plaques
Journal Article
Brain, ISSN 0006-8950, 01/2015, Volume 138, Issue 1, pp. 8 - 10
This scientific commentary refers to 'Neutralization of TNFSF10 ameliorates functional outcome in a murine model of Alzheimer's disease' by Cantarella et al.... 
APOPTOSIS | IMMUNOTHERAPY | NEUROSCIENCES | CLINICAL NEUROLOGY | Alzheimer Disease - drug therapy | Antibodies, Monoclonal - therapeutic use | Male | Animals | TNF-Related Apoptosis-Inducing Ligand - immunology | Humans | Index Medicus | Abridged Index Medicus
Journal Article
Current topics in medicinal chemistry, ISSN 1568-0266, 01/2017, Volume 17, Issue 31, p. 3318
Journal Article
Nutrients, ISSN 2072-6643, 07/2015, Volume 7, Issue 7, pp. 5764 - 5782
Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by the deposition of extracellular amyloid-beta peptide (Aβ) and intracellular... 
Antioxidants | Fibrillogenesis | Oxidative stress | Alzheimer’s disease | Nanotechnology | Apoptosis | nanotechnology | apoptosis | fibrillogenesis | antioxidants | oxidative stress
Journal Article
Molecules, ISSN 1420-3049, 08/2017, Volume 22, Issue 8
Journal Article
CURRENT NEUROPHARMACOLOGY, ISSN 1570-159X, 07/2013, Volume 11, Issue 4, pp. 388 - 413
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 02/2019, Volume 296, pp. 14 - 28
Journal Article
Journal Article
Journal of Inorganic Biochemistry, ISSN 0162-0134, 02/2018, Volume 179, pp. 82 - 96
A series of (3-hydroxy-4-pyridinone)-benzofuran hybrids have been developed and studied as potential multitargeting drugs for Alzheimer's disease (AD). Their... 
Hydroxypyridinones | Metal-modulation | Alzheimer´s disease | Benzofuran | Anti-neurodegeneration | Index Medicus
Journal Article
Current Neuropharmacology, ISSN 1570-159X, 07/2013, Volume 11, Issue 4, pp. 388 - 413
As acetylcholinesterase (AChE) inhibitors are an important therapeutic strategy in Alzheimer?s disease, efforts are being made in search of new molecules with... 
Acetylcholinesterase inhibitors | Secondary metabolites | Alzheimer’s Disease | Essential oils | Plant extracts | acetylcholinesterase inhibitors | secondary metabolites | essential oils | plant extracts
Journal Article
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, ISSN 1552-5260, 2015, Volume 11, Issue 7, pp. P373 - P373
Journal Article
Journal Article
Colloids and surfaces. B, Biointerfaces, ISSN 0927-7765, 04/2019, Volume 180, pp. 83 - 92
Journal Article
JOURNAL OF INORGANIC BIOCHEMISTRY, ISSN 0162-0134, 02/2018, Volume 179, pp. 82 - 96
A series of (3-hydroxy-4-pyridinone)-benzofuran hybrids have been developed and studied as potential multi-targeting drugs for Alzheimer's disease (AD). Their... 
Hydroxypyridinones | RIVASTIGMINE | OXIDATIVE STRESS | DESIGN | TACRINE HYBRIDS | BIOCHEMISTRY & MOLECULAR BIOLOGY | Anti-neurodegeneration | CHEMISTRY, INORGANIC & NUCLEAR | Metal-modulation | Benzofuran | DRUGS | A-BETA | FORCE-FIELD | ACETYLCHOLINESTERASE INHIBITORS | IRON-CHELATORS | Alzheimer's disease | DERIVATIVES | Antioxidants | Enzyme inhibitors | Analysis | Drug therapy | Cells | Target marketing
Journal Article
Current Pharmaceutical Design, ISSN 1381-6128, 2017, Volume 23, Issue 33, pp. 4979 - 4989
Journal Article
Molecules, ISSN 1420-3049, 07/2017, Volume 22, Issue 8, p. 1265
Tacrine (THA), the first clinically effective acetylcholinesterase (AChE) inhibitor and the first approved drug for the treatment of Alzheimer’s disease (AD),... 
Side effects | Inhibitors | Neurodegenerative diseases | Fragments | Amalgamation | Acetylcholinesterase | Huperzine A | Hepatotoxicity |